LEADER 01942nam  2200349   450 
001 9910688399303321
005 20230625180251.0
035   $a(CKB)5580000000514451
035   $a(NjHacI)995580000000514451
035   $a(EXLCZ)995580000000514451
100   $a20230625d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAntiviral Drugs $eintervention strategies /$fFarid A. Badria, editor
210  1$aLondon :$cIntechOpen,$d2022.
215   $a1 online resource (104 pages)
311   $a1-80355-332-4 
327   $a1. Introductory Chapter: An Intervention Therapeutic Strategies against SARS-CoV-2. -- 2. Perspective Chapter: Repurposing Natural Products to Target COVID-19 Molecular Targets and New Avenues for Drug Discovery.  -- 3. Antiviral Drugs and Their Roles in the Treatment of Coronavirus Infection. -- 4. Immunoinformatics and Computer-Aided Drug Design as New Approaches against Emerging and Re-Emerging Infectious Diseases. -- 5. Reprofiling of Octogenarian Antiviral Agent: A New Avenue Venture to Discover Viral Infection.
330   $aWith the increasing emergence of viral infections worldwide, researchers are working to develop new and non-conventional treatments for infectious diseases. This is particularly true for SARS-CoV-2, which initiated a pandemic in 2019. With a focus on coronavirus, this book provides an overview of antiviral agents and new approaches to drug design. It includes five chapters that address new avenues for drug discovery, reprofiling of current drugs, computer-aided drug design, and more.
606   $aAntiviral agents
615  0$aAntiviral agents.
676   $a616.925061
702   $aBadria$b Farid A.
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688399303321
996   $aAntiviral drugs$92951823
997   $aUNINA